Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

News Daily News

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

November 17, 2017

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

News Daily News

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

September 07, 2017

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

July 26, 2017

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

July 14, 2017

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

News Conference News SCAI 2017

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

May 12, 2017

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

April 12, 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

March 27, 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

News Conference News ACC 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

March 21, 2017

Live From Washington: ACC 2017, Day Two

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

March 18, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

March 01, 2017

News Daily News

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

January 11, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.